Korro Bio, Inc. (KRRO)
11.00
-0.41
(-3.59%)
USD |
NASDAQ |
Mar 19, 14:16
Korro Bio Total Assets (Quarterly) : 115.71M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cencora, Inc. | 78.36B |
| BioCryst Pharmaceuticals, Inc. | 514.16M |
| United Therapeutics Corp. | 7.969B |
| Collegium Pharmaceutical, Inc. | 1.686B |
| ProKidney Corp. | 351.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 64.27M |
| Shareholders Equity (Quarterly) | 51.44M |
| Debt to Equity Ratio | 0.8454 |
| Current Ratio | 6.901 |
| Net Debt Paydown Yield | -0.45% |